DBP International AB: Indian patent for Temodex / SI-053 is granted
Double Bond Pharmaceutical International AB (publ) ("DBP" or "The Company", org. No. 556991-6082) has today, December 7th 2020, received information about the granting of Indian patent application concerning the company's front-line product Temodex / SI-053. Patent approval provides protection for the technology and the product in India until at least 2036. "This is a very important milestone in the development of SI-053 as India is a fast-growing market where we plan to expand the global commercialization of the product," – comments Igor Lokot, CEO of DBP. – “We also have other